139 related articles for article (PubMed ID: 24618442)
1. Tensegrity model hypothesis: may this paradigm be useful to explain hepatic and pancreatic carcinogenesis in patients with persistent hepatitis B or hepatitis C virus infection?
Fiorino S; Bacchi-Reggiani L; Pontoriero L; Gallo C; Chili E; Masetti M; Zanini N; Grondona A; Silvestri T; Deleonardi G; Fornelli A; Bondi A; de Biase D; Baccarini P; Tallini G; Tropeano A; Quartuccio V; Cuppini A; Castellani G; Jovine E
JOP; 2014 Mar; 15(2):151-64. PubMed ID: 24618442
[TBL] [Abstract][Full Text] [Related]
2. HBV- and HCV-related infections and risk of pancreatic cancer.
Fiorino S; Cuppini A; Castellani G; Bacchi-Reggiani ML; Jovine E
JOP; 2013 Nov; 14(6):603-9. PubMed ID: 24216545
[TBL] [Abstract][Full Text] [Related]
3. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
Chehadeh W; Al-Nakib W
J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
[TBL] [Abstract][Full Text] [Related]
4. Coexpression network analysis in chronic hepatitis B and C hepatic lesions reveals distinct patterns of disease progression to hepatocellular carcinoma.
He D; Liu ZP; Honda M; Kaneko S; Chen L
J Mol Cell Biol; 2012 Jun; 4(3):140-52. PubMed ID: 22467683
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of dual infection of hepatitis B and C viruses among patients with chronic liver disease: a study from tertiary care hospital.
Chakravarti A; Verma V; Jain M; Kar P
Trop Gastroenterol; 2005; 26(4):183-7. PubMed ID: 16737047
[TBL] [Abstract][Full Text] [Related]
6. Chronic hepatitis B virus and hepatitis C virus infections and cancer: synergy between viral and host factors.
Schinzari V; Barnaba V; Piconese S
Clin Microbiol Infect; 2015 Nov; 21(11):969-74. PubMed ID: 26163104
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B and C virus-related carcinogenesis.
Fung J; Lai CL; Yuen MF
Clin Microbiol Infect; 2009 Nov; 15(11):964-70. PubMed ID: 19874379
[TBL] [Abstract][Full Text] [Related]
8. Association between hepatitis B or hepatitis C virus infection and risk of pancreatic adenocarcinoma development: a systematic review and meta-analysis.
Fiorino S; Chili E; Bacchi-Reggiani L; Masetti M; Deleonardi G; Grondona AG; Silvestri T; Magrini E; Zanini N; Cuppini A; Nardi R; Jovine E
Pancreatology; 2013; 13(2):147-60. PubMed ID: 23561973
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B and C virus infections as possible risk factor for pancreatic adenocarcinoma.
Fiorino S; Lorenzini S; Masetti M; Deleonardi G; Grondona AG; Silvestri T; Chili E; Del Prete P; Bacchi-Reggiani L; Cuppini A; Jovine E
Med Hypotheses; 2012 Nov; 79(5):678-97. PubMed ID: 22959312
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
Eyre NS; Phillips RJ; Bowden S; Yip E; Dewar B; Locarnini SA; Beard MR
J Hepatol; 2009 Sep; 51(3):446-57. PubMed ID: 19596477
[TBL] [Abstract][Full Text] [Related]
11. The role of oncogenic viruses in the pathogenesis of hepatocellular carcinoma.
Zemel R; Issachar A; Tur-Kaspa R
Clin Liver Dis; 2011 May; 15(2):261-79, vii-x. PubMed ID: 21689612
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic expression of hepatitis B virus antigens: effect of hepatitis C virus infection.
Guido M; Thung SN; Fattovich G; Cusinato R; Leandro G; Cecchetto A; Cesaro S; Panese P; Rugge M
Mod Pathol; 1999 Jun; 12(6):599-603. PubMed ID: 10392636
[TBL] [Abstract][Full Text] [Related]
13. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
[TBL] [Abstract][Full Text] [Related]
14. [HBV and HCV coinfections in children--own investigations].
Pawłowska M; Halota W
Przegl Epidemiol; 2003; 57(3):459-64. PubMed ID: 14682164
[TBL] [Abstract][Full Text] [Related]
15. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis.
Sagnelli E; Coppola N; Scolastico C; Filippini P; Santantonio T; Stroffolini T; Piccinino F
Hepatology; 2000 Nov; 32(5):1106-10. PubMed ID: 11050062
[TBL] [Abstract][Full Text] [Related]
16. Genetic variability of hepatitis B and C viruses in Brazilian patients with and without hepatocellular carcinoma.
Araujo OC; Barros JJ; do Ó KM; Nabuco LC; Luz CA; Perez RM; Niel C; Villela-Nogueira CA; Araujo NM
J Med Virol; 2014 Feb; 86(2):217-23. PubMed ID: 24338810
[TBL] [Abstract][Full Text] [Related]
17. [Features of combined (HBV/HCV-infection) viral lesion of the liver].
Maev IV; Nikushkina IN; Samsonov AA; Aksel'rod AG
Ter Arkh; 2008; 80(2):57-61. PubMed ID: 18372598
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC): molecular mechanisms and novel paradigms.
Brechot C; Kremsdorf D; Soussan P; Pineau P; Dejean A; Paterlini-Brechot P; Tiollais P
Pathol Biol (Paris); 2010 Aug; 58(4):278-87. PubMed ID: 20667665
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of chronic hepatitis in children with cancer.
Sevinir B; Meral A; Günay U; Ozkan T; Ozuysal S; Sinirtas M
Med Pediatr Oncol; 2003 Feb; 40(2):104-10. PubMed ID: 12461794
[TBL] [Abstract][Full Text] [Related]
20. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
